Db Fitzpatrick & Co, Inc Danaher Corp Transaction History

Db Fitzpatrick & Co, Inc

$107 Million
Q2 2024

A detailed history of Db Fitzpatrick & Co, Inc transactions in Danaher Corp stock. As of the latest transaction made, Db Fitzpatrick & Co, Inc holds 8,421 shares of DHR stock, worth $2.26 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares

8,421

Previous 8,459 0.45%

Holding current value

$2.26 Million

Previous $2.11 Million 0.43%

% of portfolio

1.96%

Previous 1.95%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$235.51 - $267.98 $8,949 - $10,183	-38 Reduced 0.45%	8,421 $2.1 Million
Q1 2024 Apr 19, 2024	SELL	$224.58 - $256.19 $11,678 - $13,321	-52 Reduced 0.61%	8,459 $2.11 Million
Q4 2023 Jan 23, 2024	BUY	$185.1 - $233.13 $1,665 - $2,098	9 Added 0.11%	8,511 $1.97 Million
Q3 2023 Nov 01, 2023	BUY	$233.08 - $265.59 $54,074 - $61,616	232 Added 2.81%	8,502 $2.11 Million
Q2 2023 Aug 09, 2023	SELL	$224.99 - $256.14 $78,296 - $89,136	-348 Reduced 4.04%	8,270 $1.98 Million
Q1 2023 Apr 24, 2023	BUY	$239.75 - $277.0 $59,458 - $68,696	248 Added 2.96%	8,618 $2.17 Million
Q4 2022 Jan 24, 2023	SELL	$241.42 - $282.29 $43,938 - $51,376	-182 Reduced 2.13%	8,370 $0
Q3 2022 Oct 20, 2022	SELL	$247.06 - $1507.4 $194,189 - $1.18 Million	-786 Reduced 8.42%	8,552 $2.21 Million
Q2 2022 Jul 28, 2022	BUY	$237.11 - $299.66 $79,668 - $100,685	336 Added 3.73%	9,338 $2.37 Million
Q1 2022 Apr 22, 2022	BUY	$257.27 - $315.76 $55,570 - $68,204	216 Added 2.46%	9,002 $2.64 Million
Q4 2021 Feb 03, 2022	BUY	$292.08 - $329.01 $2.57 Million - $2.89 Million	8,786 New	8,786 $2.89 Million

Others Institutions Holding DHR

# of Institutions

2,394

Shares Held

563M

Call Options Held

3.94M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $196B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Db Fitzpatrick & Co, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Db Fitzpatrick & Co, Inc with notifications on news.

Account

Db Fitzpatrick & Co, Inc Danaher Corp Transaction History